RDM1
RAD52 motif-containing protein 1
Also known as: MGC33977, RAD52B, RDM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NG50
- Gene
- RDM1
- Ensembl
- ENSG00000278023
- Chromosome
- 17
- Canonical length
- 284 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein involved in the cellular response to cisplatin, a drug commonly used in chemotherapy. The protein encoded by this gene contains two motifs: a motif found in RAD52, a protein that functions in DNA double-strand breaks and homologous recombination, and an RNA recognition motif (RRM) that is not found in RAD52. The RAD52 motif region in RAD52 is important for protein function and may be involved in DNA binding or oligomerization. Alternatively spliced transcript variants encoding different isoforms have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
284 residues, UniProt reviewed canonical sequence.
>Q8NG50|RDM1
1 MAELVPFAVP IESDKTLLVW ELSSGPTAEA LHHSLFTAFS QFGLLYSVRV FPNAAVAHPG
61 FYAVIKFYSA RAAHRAQKAC DRKQLFQKSP VKVRLGTRHK AVQHQALALN SSKCQELANY
121 YFGFNGCSKR IIKLQELSDL EERENEDSMV PLPKQSLKFF CALEVVLPSC DCRSPGIGLV
181 EEPMDKVEEG PLSFLMKRKT AQKLAIQKAL SDAFQKLLIV VLESGKIAVE YRPSEDIVGV
241 RCEEELHGLI QVPCSPWKQY GQEEEGYLSD FSLEEEEFRL PELDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RDM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- thymus: 2.2 nTPM
- tonsil: 1.3 nTPM
- basal ganglia: 1 nTPM
- lymph node: 1 nTPM
- duodenum: 0.8 nTPM
Single-cell type
- late spermatids: 114 nCPM
- early spermatids: 52 nCPM
- late primary spermatocytes: 23 nCPM
- early primary spermatocytes: 9.3 nCPM
- megakaryocytes: 6.2 nCPM
- megakaryocyte progenitors: 2.6 nCPM
Immune cell
- memory CD8 T-cell: 2.6 nTPM
- MAIT T-cell: 1.3 nTPM
- memory CD4 T-cell: 0.8 nTPM
- gdT-cell: 0.7 nTPM
- NK-cell: 0.6 nTPM
- T-reg: 0.5 nTPM
Brain region
- cerebellum: 4.3 nTPM
- basal ganglia: 3.2 nTPM
- cerebral cortex: 3.1 nTPM
- hippocampal formation: 3 nTPM
- hypothalamus: 2.9 nTPM
- pons: 2.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- RDM1, RNA recognition motif
- RAD52 motif-containing protein 1
- RDM1, DSRM domain
- RDM1 DSRM domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RDM1 as an antibody target. Whether an autoantibody or antibody against RDM1 could matter depends on whether native RDM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RDM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RDM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...